Pharmacology

Action Mechanism of Action Reference
AGONIST Glucagon-like peptide 1 receptor agonist FDA
Primary Target
GLP-1 receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Acute Coronary Syndrome 3 D054058 ClinicalTrials
Parkinson Disease 2 D010300 ClinicalTrials
Diabetes Mellitus, Type 1 1 D003922 ClinicalTrials

Related Entries

Mixture

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
12.86
General disorders and administration site conditions
12.07
Vascular disorders
6.82
Cardiac disorders
6.3
Respiratory, thoracic and mediastinal disorders
6.04
Hepatobiliary disorders
5.25
Investigations
5.25
Injury, poisoning and procedural complications
4.99
Nervous system disorders
4.99
Metabolism and nutrition disorders
4.72
Infections and infestations
4.46
Endocrine disorders
4.2
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
3.94
Skin and subcutaneous tissue disorders
3.94
Psychiatric disorders
2.62
Reproductive system and breast disorders
2.36
Immune system disorders
2.1

Cross References

Resources Reference
CAS NUMBER 320367-13-3
ChEMBL CHEMBL2108336
FDA SRS 74O62BB01U
Guide to Pharmacology 7387